盐酸考来替泊片药品报告提供了盐酸考来替泊片的各种信息,包括盐酸考来替泊片的药品简介,新药研发进度,仿制药申报进度,中国药品注册情况,一致性评价进度,药品临床试验进度,药品上市等信息.更多药物报告的查询就在戊戌数据药物报告数据库.
戊戌数据药品标准数据库提供了Colestipol Hydrochloride Tablets盐酸考来替泊片美国药典标准的查询检索,包括Colestipol Hydrochloride Tablets盐酸考来替泊片美国药典的版本USP35-NF30页码,以及药典的查询与下载.
of Colestipol hydrochloride (I) effective for treating or preventing hypercholesterolemia in a patient to whom one or more tablets are administered, and has the following physical characteristics: hardness 40-75 SCUs; thickness 0.200-0.340 inch; and friability 0-0.1%/15 mins.. (I) is finely ...
Since colestipol hydrochloride is an anion exchange resin, it may have a strongaffinityfor anions other than thebileacids. In vitro studies have indicated that colestipol hydrochloride binds a number of drugs. Therefore, COLESTID Tablets may delay or reduce the absorption of concomitant oral medic...
4, 2023-- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Colestipol Hydrochloride Tablets USP, 1 g. ...
of Colestipol hydrochloride (I) effective for treating or preventing hypercholesterolemia in a patient to whom one or more tablets are administered, and has the following physical characteristics: hardness 40-75 SCUs; thickness 0.200-0.340 inch; and friability 0-0.1%/15 mins.. (I) is finely ...
Colestipol hydrochloride high-content tabletsdoi:EP0592594 B1EP
Said invention particularly relates to new and unique in their kind tablets of 1000 mg colestipol hydrochloride having the advantageous properties of hardness and low friability and a novel process for manufacture of these tablets.doi:WO1993000915 A1SHEN Robert Wu-wei...
Conventional colestipol hydrochloride was heretoforth available in spherical granules which produced less elegant (gritty) oral suspensions and oral tablets with substantially lower doses of drug (e.g., ca 500 mg).MCCURDY, VINCENT, E.SPILMAN, CHARLES, H....
Conventional colestipol hydrochloride was heretoforth available in spherical granules which produced less elegant (gritty) oral suspensions and oral tablets with substantially lower doses of drug (e.g., ca 500 mg).